Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MLAB logo MLAB
Upturn stock ratingUpturn stock rating
MLAB logo

Mesa Laboratories Inc (MLAB)

Upturn stock ratingUpturn stock rating
$67.89
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: MLAB (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $88.5

1 Year Target Price $88.5

Analysts Price Target For last 52 week
$88.5 Target price
52w Low $55.45
Current$67.89
52w High $154.7

Analysis of Past Performance

Type Stock
Historic Profit -51.1%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 373.49M USD
Price to earnings Ratio -
1Y Target Price 88.5
Price to earnings Ratio -
1Y Target Price 88.5
Volume (30-day avg) 4
Beta 0.83
52 Weeks Range 55.45 - 154.70
Updated Date 08/15/2025
52 Weeks Range 55.45 - 154.70
Updated Date 08/15/2025
Dividends yield (FY) 0.92%
Basic EPS (TTM) -0.13

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-08-04
When Before Market
Estimate 2.38
Actual 1.8811

Profitability

Profit Margin -0.26%
Operating Margin (TTM) 5.15%

Management Effectiveness

Return on Assets (TTM) 2.04%
Return on Equity (TTM) -0.38%

Valuation

Trailing PE -
Forward PE 35.21
Enterprise Value 549807712
Price to Sales(TTM) 1.54
Enterprise Value 549807712
Price to Sales(TTM) 1.54
Enterprise Value to Revenue 2.27
Enterprise Value to EBITDA 12.14
Shares Outstanding 5501450
Shares Floating 5344443
Shares Outstanding 5501450
Shares Floating 5344443
Percent Insiders 5.12
Percent Institutions 95.7

ai summary icon Upturn AI SWOT

Mesa Laboratories Inc

stock logo

Company Overview

overview logo History and Background

Mesa Laboratories, Inc. was founded in 1982. It has evolved from a focus on quality control products for healthcare to a broader range of instruments, consumables, and services for life sciences, healthcare, and industrial applications. Mesa Labs has grown through organic expansion and strategic acquisitions.

business area logo Core Business Areas

  • Sterilization and Disinfection Control: Provides biological indicators, chemical indicators, and process challenge devices used to monitor sterilization and disinfection processes in healthcare and industrial settings.
  • Biopharmaceutical Development: Offers contract manufacturing and analytical testing services for biopharmaceutical companies.
  • Instruments: Designs and manufactures instruments used for environmental monitoring, calibration, and data logging across various industries.

leadership logo Leadership and Structure

The leadership team includes the CEO, CFO, and other key executives responsible for different business segments. The company has a board of directors overseeing strategy and governance. Typically follows a functional organizational structure with departments like R&D, Sales, Marketing, and Operations.

Top Products and Market Share

overview logo Key Offerings

  • Biological Indicators (BIs): Used to validate sterilization processes. Market share information is not readily and publicly available. Competitors include STERIS (STE), 3M (MMM) and Getinge AB (GETI-B.ST).
  • Data Loggers: Used for continuous monitoring of temperature, humidity, and pressure. Market share information is not readily and publicly available. Competitors include Vaisala, Dickson and MadgeTech.
  • Contract Sterility Testing Services: Services provided to pharmaceutical companies for drug product testing. Market share information is not readily and publicly available. Competitors include SGS S.A. (SGSO.SW), Charles River Laboratories (CRL) and Eurofins Scientific (ERF.PA).

Market Dynamics

industry overview logo Industry Overview

The industry includes sterilization and disinfection control, contract manufacturing and analytical testing, and environmental monitoring. Growth is driven by increasing regulatory requirements, healthcare spending, and demand for biopharmaceuticals.

Positioning

Mesa Laboratories positions itself as a provider of high-quality, reliable solutions for critical quality control and testing needs. Its competitive advantages include its strong brand reputation, technical expertise, and focus on niche markets.

Total Addressable Market (TAM)

The TAM across its segments is estimated to be several billion USD annually. Mesa Labs is positioned to capture a portion of this market through its specialized offerings.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Technical expertise
  • Focus on niche markets
  • Recurring revenue streams
  • High regulatory barriers to entry

Weaknesses

  • Limited scale compared to larger competitors
  • Dependence on specific industries
  • Potential for technological obsolescence
  • Relatively high valuation metrics

Opportunities

  • Expansion into new geographic markets
  • Development of new products and services
  • Acquisitions of complementary businesses
  • Increased outsourcing of biopharmaceutical services
  • Growing regulatory requirements

Threats

  • Intense competition
  • Economic downturns
  • Changes in regulatory requirements
  • Technological advancements by competitors
  • Supply chain disruptions

Competitors and Market Share

competitor logo Key Competitors

  • STE
  • MMM
  • CRL

Competitive Landscape

Mesa Laboratories competes with larger companies in some segments, but it has a competitive advantage in niche markets due to its specialized expertise and strong brand reputation.

Major Acquisitions

Apex Pro LLC

  • Year: 2021
  • Acquisition Price (USD millions): 81
  • Strategic Rationale: Expanded presence in the medical device industry and expanded access to customers.

Growth Trajectory and Initiatives

Historical Growth: Mesa Laboratories has historically grown through a combination of organic growth and strategic acquisitions.

Future Projections: Future growth projections depend on continued demand for its products and services, as well as successful execution of its acquisition strategy.

Recent Initiatives: Recent strategic initiatives may include acquisitions of companies in complementary markets or investments in new technologies.

Summary

Mesa Laboratories is a strong company with a focus on niche markets and high regulatory barriers. The company has a good brand reputation and is growing, but it has limited scale compared to larger competitors and a relatively high valuation. Going forward, MLAB needs to continue investing in innovation to stave off competitors.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (10-K, 10-Q)
  • Analyst reports
  • Industry publications
  • Company Website

Disclaimers:

This analysis is based on available information and is not financial advice. Market conditions and company performance are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Mesa Laboratories Inc

Exchange NASDAQ
Headquaters Lakewood, CO, United States
IPO Launch date 1995-01-25
CEO, President & Director Mr. Gary M. Owens
Sector Technology
Industry Scientific & Technical Instruments
Full time employees 730
Full time employees 730

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.